As part of the terms of the Marketing Authorisation for Daptomycin, Accord Healthcare Limited are required to ensure that all Healthcare Professionals who are likely to treat patients with daptomycin are provided with risk minimisation materials. This document contains key information to help minimize the risks of myotoxicity and dysregulation of in vivo coagulation. It also provides dosage recommendations and calculates the volume of volume of daptomycin 50 mg/ml solution that is required from the weight of the patient. If you require further information about daptomycin and hard copies of the material please contact [email protected] If you have any questions or require additional information, please call Accord Healthcare Limited Medical Information Services on (0)1271 385 257.
For Healthcare Professionals